The "development of race-based products such as vitamins and drugs" by pharmaceutical manufacturers is "misleading the public to believe that races are biologically distinct, requiring race-specific products, but the basis for their wares flies in the face of science," Susanne Haga, an assistant research professor at Duke University's Institute for Genome Sciences Policy and Public Policy, writes in a
(more...)